TEL2 inhibitors belong to a specialized category of chemical compounds that have garnered attention in the field of molecular biology and cell cycle regulation. TEL2, which stands for "Telomere Maintenance 2," is a protein involved in maintaining genomic stability and influencing cellular processes, particularly in the context of telomere maintenance and DNA repair. Telomeres are the protective caps at the ends of chromosomes, and they play a crucial role in preserving chromosome integrity and preventing genomic instability. TEL2 is associated with the telomerase complex, an enzyme responsible for extending telomeres and counteracting their natural shortening with each cell division. TEL2 inhibitors are chemical compounds designed to interact with TEL2, influencing its role in telomere maintenance and DNA repair processes.
The mechanism of action of TEL2 inhibitors typically involves their binding to the TEL2 protein, often at specific binding sites or domains. This interaction can lead to changes in TEL2's function, potentially affecting its ability to participate in telomere maintenance and DNA repair. Consequently, TEL2 inhibitors may have implications for various cellular processes that rely on intact telomeres, including genomic stability and cellular proliferation. The study of TEL2 inhibitors is crucial for advancing our understanding of the molecular mechanisms underlying telomere biology and DNA repair, shedding light on how these processes contribute to the maintenance of genomic integrity and cellular function. Additionally, it contributes to the broader field of cell biology and molecular genetics, offering insights into the intricate regulatory networks that govern telomere dynamics and their impact on cellular physiology.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG, an HSP90 inhibitor, may disrupt the chaperone function necessary for TEL2-stabilized PIKKs, potentially reducing TEL2 protein levels indirectly. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
As an HSP90 inhibitor, Geldanamycin may compromise the chaperone-assisted maturation of TEL2 client proteins, indirectly influencing TEL2 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus inhibits mTOR, a member of the PIKK family and a potential TEL2 interaction partner, possibly affecting TEL2 expression or stability. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This PI3K inhibitor could disrupt PIKK signaling pathways, which may include those involving TEL2, thereby potentially affecting its expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As an inhibitor of PI3K and related PIKKs, Wortmannin might indirectly decrease the expression or stability of TEL2. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and disrupts RNA synthesis, which could lead to a reduction in TEL2 mRNA and protein expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide blocks the translocation step in protein synthesis, potentially reducing the overall levels of proteins, including TEL2. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide inhibits transcriptional activity, which may decrease the transcription of many genes, potentially including TEL2. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C forms DNA crosslinks, possibly leading to reduced transcription and subsequent lower levels of TEL2 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine disrupts lysosomal function and nucleic acid synthesis, potentially affecting a wide range of genes, including TEL2. | ||||||